Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 41 descriptions
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil (D00407) | 4件: Methylprednisolone Methylprednisolone,Mycophenolate mofetil, Mycophenolic acid, Prednisone | 4件: Methylprednisolone
Methylprednisolone
(D00407),Prednisone , Mycophenolate mofetil , Mycophenolic acid 💬 1. Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
| 3件: IMPDH1 IMPDH1,IMPDH2, NR3C1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬 5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nu ... | 1件: 49 49 💬1. Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
| ||||||||||||||||
2 | Administration of methylprednisolone, paracetamol and dexchlorpheniramine (D00407) | 3件: Acetaminophen Acetaminophen,Dexchlorpheniramine, Methylprednisolone | 3件: Acetaminophen
Acetaminophen
,Methylprednisolone (D00407), Dexchlorpheniramine 💬 2. Administration of methylprednisolone, paracetamol and dexchlorpheniramine
| 4件: HRH1 HRH1,NR3C1, PTGS1, PTGS2 💬 | 26件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calci ... | 1件: 49 49 💬2. Administration of methylprednisolone, paracetamol and dexchlorpheniramine
| ||||||||||||||||
3 | Administration of rituximab and methylprednisolone (D00407) | 2件: Methylprednisolone Methylprednisolone,Rituximab | 2件: Methylprednisolone
Methylprednisolone
(D00407),Rituximab 💬 3. Administration of rituximab and methylprednisolone
| 2件: MS4A1 MS4A1,NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 💬3. Administration of rituximab and methylprednisolone
| ||||||||||||||||
4 | Corticosteroid treatment (Methylprednisolone or prednisolone) (D00407) | 2件: Methylprednisolone Methylprednisolone,Prednisolone | 2件: Methylprednisolone
Methylprednisolone
(D00407),Prednisolone 💬 4. Corticosteroid treatment (Methylprednisolone or prednisolone)
| 1件: NR3C1 NR3C1 💬4. Corticosteroid treatment (Methylprednisolone or prednisolone)
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 64 64 💬4. Corticosteroid treatment (Methylprednisolone or prednisolone)
| ||||||||||||||||
5 | Cyclophosphamide, Azathioprine,prednisone,methylprednisolone (D00407) | 4件: Azathioprine Azathioprine,Cyclophosphamide, Methylprednisolone, Prednisone | 5件: Azathioprine
Azathioprine
,Cyclophosphamide , Methylprednisolone (D00407), Prednisone , Cyclophosphamide 💬 5件: Azathioprine , Cyclophosphamide , Methylprednisolone (D00407), Prednisone , Cyclophosp ... 5. Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
| 1件: NR3C1 NR3C1 💬5. Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 42 42, 43, 45 💬
| ||||||||||||||||
6 | Infliximab, methylprednisolone, methotrexate (D00407) | 3件: Infliximab Infliximab,Methotrexate, Methylprednisolone | 3件: Methotrexate
Methotrexate
,Methylprednisolone (D00407), Infliximab 💬 6. Infliximab, methylprednisolone, methotrexate
| 4件: DHFR DHFR,DHFR2, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African ... | 1件: 46 46 💬6. Infliximab, methylprednisolone, methotrexate
| ||||||||||||||||
7 | Interferon-beta-1a (Avonex) plus methylprednisolone (D00407) | 3件: Human interferon beta Human interferon beta,Interferon beta-1a, Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
(D00407),Interferon beta-1a 💬 7. Interferon-beta-1a (Avonex) plus methylprednisolone
| 3件: IFNAR1 IFNAR1,IFNAR2, NR3C1 💬 | 19件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 19件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infe ... | 1件: 13 13 💬7. Interferon-beta-1a (Avonex) plus methylprednisolone
| ||||||||||||||||
8 | Intravenous (i.v.) methylprednisolone 1000 mg, total 9 (D00407) | 1件: Methylprednisolone Methylprednisolone | 1件: Methylprednisolone
Methylprednisolone
(D00407) 💬8. Intravenous (i.v.) methylprednisolone 1000 mg, total 9
| 1件: NR3C1 NR3C1 💬8. Intravenous (i.v.) methylprednisolone 1000 mg, total 9
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬8. Intravenous (i.v.) methylprednisolone 1000 mg, total 9
| ||||||||||||||||
9 | Intravenous Methylprednisolone (D00407) | 1件: Methylprednisolone Methylprednisolone | 1件: Methylprednisolone
Methylprednisolone
(D00407) 💬9. Intravenous Methylprednisolone
| 1件: NR3C1 NR3C1 💬9. Intravenous Methylprednisolone
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 145 💬
| ||||||||||||||||
10 | IV methylprednisolone (D00407) | 1件: Methylprednisolone Methylprednisolone | 1件: Methylprednisolone
Methylprednisolone
(D00407) 💬10. IV methylprednisolone
| 1件: NR3C1 NR3C1 💬10. IV methylprednisolone
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬10. IV methylprednisolone
|